School of Public Health, Imperial College London, London, UK.
Interstitial Lung Disease Unit, Royal Brompton Hospital and Harefield NHS Foundation Trust, London, UK.
NPJ Prim Care Respir Med. 2024 Oct 9;34(1):27. doi: 10.1038/s41533-024-00387-6.
The benefits of pulmonary rehabilitation (PR) and palliative care (PC) as non-pharmacological therapies for people with idiopathic pulmonary fibrosis (IPF) are increasingly being recognised but in the UK the proportion of people with this life-limiting condition who are referred to such services is thought to be low. This retrospective cohort study aimed to describe trends in referrals to PR and PC services among people with IPF over a 10-year period and to identify factors associated with non-referral. Our study cohort was drawn from the UK's pseudonymised Clinical Practice Research Datalink (CPRD) Aurum primary care database and comprised 17,071 individuals diagnosed with IPF between 2010 and 2019. While 12.0% of IPF patients were offered a referral to PR, less than 2% completed a PR programme. Around a fifth (19.4%) received a referral to generic PC support services; however, this is well below reported PC referral rates for lung cancer patients. Moreover, the majority of PC referrals occurred late; among those who died, 31% were referred within a month and 70% within 6 months of death. Referrals to PR and PC had however increased (by around 2-fold and 4-fold, respectively) over the course of the study period. Factors associated with non-referral to PR included female sex, older age and co-diagnosis of dementia; barriers to PC referral included being female or of Asian or Black ethnicity. We also found evidence of regional differences in referrals. These findings confirm that PR and PC service provision for people with IPF across England is suboptimal.
肺康复 (PR) 和姑息治疗 (PC) 作为治疗特发性肺纤维化 (IPF) 患者的非药物疗法的益处日益得到认可,但在英国,被转介到此类服务的这种危及生命的疾病患者比例被认为很低。这项回顾性队列研究旨在描述在 10 年期间,IPF 患者转介到 PR 和 PC 服务的趋势,并确定与未转介相关的因素。我们的研究队列来自英国的假名化临床实践研究数据链接 (CPRD) Aurum 初级保健数据库,其中包括 2010 年至 2019 年间被诊断为 IPF 的 17071 个人。虽然 12.0%的 IPF 患者被提供 PR 转介,但只有不到 2%的患者完成了 PR 计划。大约五分之一(19.4%)接受了通用 PC 支持服务的转介;然而,这远低于肺癌患者报告的 PC 转介率。此外,大多数 PC 转介发生在晚期;在那些死亡的患者中,31%在死亡前一个月内被转介,70%在死亡前 6 个月内被转介。然而,PR 和 PC 的转介数量有所增加(分别增加了约 2 倍和 4 倍)。与未转介到 PR 相关的因素包括女性、年龄较大和合并痴呆诊断;PC 转介的障碍包括女性或亚洲或黑人种族。我们还发现了转介方面存在地区差异的证据。这些发现证实,英格兰为 IPF 患者提供的 PR 和 PC 服务提供情况并不理想。